Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression
Zhongze Wang, Huarui Cai, Erhu Zhao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 25

Showing 25 citing articles:

Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies
Wooli Bae, Eun A., Myon‐Hee Lee
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Integration of metabolomic and brain-imaging data highlights pleiotropy among posttraumatic stress disorder, glycoprotein acetyls, and pallidum structure
Solveig Løkhammer, Markos Tesfaye, Brenda Cabrera‐Mendoza, et al.
Biological Psychiatry Global Open Science (2025), pp. 100482-100482
Open Access
FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature
Navin B. Ramakrishna, Umar Bin Mohamad Sahari, Yoshikazu Johmura, et al.
The American Journal of Human Genetics (2025)
Closed Access
KDM4B modulates autocrine IL6 in erythroblasts to prevent ineffective erythropoiesis
Peng Zheng, Dan Su, Jingjing Xu, et al.
Leukemia (2025)
Closed Access
Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy
Wei Sun, Erhu Zhao, Hongjuan Cui
International Journal of Cancer (2022) Vol. 152, Iss. 12, pp. 2446-2463
Closed Access | Times Cited: 16
Echinomycin as a promising therapeutic agent against KSHV-related malignancies
Jungang Chen, Zhen Lin, Jiao Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
KDM4B mutations in human cancers
Wesley Bush, Korey Bosart, Renee A. Bouley, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 829, pp. 111866-111866
Open Access | Times Cited: 2
Yam Carbon Dots Promote Bone Defect Repair by Modulating Histone Demethylase 4B
Qianyang Chen, Shuo Liu, Y. Andrew Wang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10415-10434
Open Access | Times Cited: 2
Epigenetic regulation of TGF-β and vice versa in cancers – A review on recent developments
Ankit Naik, Noopur Thakur
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189219-189219
Closed Access | Times Cited: 2
KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner
Xinyu Wang, Hongmin Li, Xia Ran, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 915-928
Closed Access | Times Cited: 5
Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression
Rashmi Srivastava, Rubi Singh, Shaurya Jauhari, et al.
Epigenomes (2023) Vol. 7, Iss. 2, pp. 10-10
Open Access | Times Cited: 4
KDM4B: A promising oncology therapeutic target
Fangjing Ni, Heting Tang, Siteng Cheng, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 8-16
Open Access | Times Cited: 4
Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication
James Michael Harris, Andrea Magrì, Ana Rita Faria, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105724-105724
Open Access | Times Cited: 1
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Kristian A. Choate, Evan P.S. Pratt, Matthew J. Jennings, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 885-885
Open Access | Times Cited: 1
Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations
Ryia Illani Mohd Yunos, Nurul‐Syakima Ab Mutalib, Jia-Shiun Khoo, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 3
Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability
Zhongze Wang, Huarui Cai, Zekun Li, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Human phenotype caused by biallelic KDM4B frameshift variant
Sanami Takada, Sebastián Silva, Ivonne Zamorano, et al.
Clinical Genetics (2023) Vol. 105, Iss. 1, pp. 72-76
Closed Access | Times Cited: 2
Genotype–phenotype correlation study of structural abnormalities in a fetal brain caused by a novel KDM4B variant
Xuliang Zhao, Xu Li, Min Yu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
KDM4B Histone Demethylase Inhibition Attenuates Tumorigenicity of Malignant Melanoma Cells by Overriding the p53‐Mediated Tumor Suppressor Pathway
Arif Ul Hasan, Satoshi Serada, Sachiko Sato, et al.
Journal of Cellular Biochemistry (2024)
Closed Access
Targeting N‐methyl‐lysine histone demethylase KDM4 in cancer: natural products inhibitors as a driving force for epigenetic drug discovery
Ilaria Cursaro, Leonardo Milioni, Kaveh Eslami, et al.
ChemMedChem (2024)
Open Access
Histone demethylase KDM4B epigenetically controls NLRP3 expression to enhance inflammatory responses
Wei Zhao, Tong Li, Hui Song, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
Tae‐Dong Kim, Ruicai Gu, Ralf Janknecht
PubMed (2023) Vol. 14, Iss. 6, pp. 101-115
Closed Access | Times Cited: 1
Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells
Huarui Cai, Zhongze Wang, Wenhan Tang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 2
Inhibitors of Jumonji-C domain-containing histone demethylases
Veronica Sian, José A. Souto, Rosana Álvarez, et al.
Elsevier eBooks (2023), pp. 407-457
Closed Access
The role of VRK1 in chromatin remodeling: regulation of histone post-translational modifications and epigenetic enzymes
Eva Monte Serrano
(2023)
Open Access
Page 1

Scroll to top